In a national cohort study of more than 6 million patient-years, researchers evaluated whether the number of patients seen annually by physicians and advanced practitioners in nursing homes influenced...
Patients with chronic obstructive pulmonary disease who recovered from COVID-19 had nearly double the risk of long-term mortality compared with matched controls, with the highest risk observed in severe...
In a phase 2b trial, efruxifermin significantly improved liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis, with the 50 mg dose showing the greatest benefit.
Postdischarge ondansetron cut the risk of moderate-to-severe gastroenteritis in children by half, without increasing adverse events or health care use.
Two-year data from the long-term phase 3 ALLEGRO-LT study suggest ritlecitinib maintains long-term clinical efficacy with a manageable safety profile in patients with moderate to severe alopecia areata.
...
A 12-week randomized controlled trial found that group-based music therapy improved social communication, sociability, and language abilities in children with autism spectrum disorder.
New findings from a large, pragmatic trial found that daily full-body emollient application beginning by 9 weeks of age significantly reduced the cumulative incidence of atopic dermatitis by 24 months.
...
Using national survey data and interpretable machine learning, researchers identified specific per- and polyfluoroalkyl substances that either increase or reduce the risk of chronic obstructive pulmonary...
A retrospective cohort study found that patients undergoing outpatient GI procedures who received opioids intra- or post-operatively reported lower pain scores and fewer instances of postoperative nausea...
Clinicians assessing health-related quality of life in children with epilepsy now have clearer benchmarks. A new study provides the first estimates of the minimum clinically important difference for the...
